| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $71.3M | +9.4% |
| Cost of Revenue | $19.6M | +26.9% |
| Gross Profit | $51.7M | +4.0% |
| R&D Expense | $9.5M | +1.9% |
| SG&A Expense | $25.4M | -0.4% |
| Operating Income | -$30.6M | +13.0% |
| Interest Expense | $5.4M | +27.6% |
| Net Income | -$30.2M | +18.8% |
| EPS (Basic) | -$1.05 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $59.7M | -15.2% |
| Accounts Receivable | $15.8M | +16.1% |
| Inventory | $8.1M | -9.1% |
| Current Assets | $93.8M | -5.0% |
| Total Assets | $115.8M | -0.9% |
| Current Liabilities | $19.8M | -40.3% |
| Long-term Debt | $59.3M | +64.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.0M | -4.2% |
| Investing Cash Flow | -$1.3M | -119.6% |
| Financing Cash Flow | $22.7M | — |
| +23.9% |
| EPS (Diluted) | -$1.05 | +23.9% |
| Total Liabilities |
| $81.6M |
| +36.5% |
| Stockholders' Equity | $34.2M | -40.1% |